310 related articles for article (PubMed ID: 7582504)
1. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT.
Gartside SE; Umbers V; Hajós M; Sharp T
Br J Pharmacol; 1995 Jul; 115(6):1064-70. PubMed ID: 7582504
[TBL] [Abstract][Full Text] [Related]
2. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
3. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
4. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine.
Hajós M; Gartside SE; Sharp T
Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):624-9. PubMed ID: 7675121
[TBL] [Abstract][Full Text] [Related]
6. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
Hajós M; Hajós-Korcsok E; Sharp T
Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
Tao R; Ma Z; Auerbach SB
J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
Gartside SE; Umbers V; Sharp T
Psychopharmacology (Berl); 1997 Apr; 130(3):261-8. PubMed ID: 9151361
[TBL] [Abstract][Full Text] [Related]
10. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
11. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
[TBL] [Abstract][Full Text] [Related]
12. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
13. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
Besson A; Haddjeri N; Blier P; de Montigny C
Eur Neuropsychopharmacol; 2000 May; 10(3):177-88. PubMed ID: 10793320
[TBL] [Abstract][Full Text] [Related]
14. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
Bermack JE; Haddjeri N; Debonnel G
J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
17. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.
Romero L; Bel N; Artigas F; de Montigny C; Blier P
Neuropsychopharmacology; 1996 Oct; 15(4):349-60. PubMed ID: 8887989
[TBL] [Abstract][Full Text] [Related]
18. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
Gundlah C; Hjorth S; Auerbach SB
Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
[TBL] [Abstract][Full Text] [Related]
19. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
Castro E; Tordera RM; Hughes ZA; Pei Q; Sharp T
J Neurochem; 2003 Jun; 85(6):1480-7. PubMed ID: 12787067
[TBL] [Abstract][Full Text] [Related]
20. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]